SCHEMBL2687

SCHEMBL2687

CCOC(=O)C(CNCc1ccc(-c2ccccc2C#N)cc1)C(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.45
WDR5 P61964 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.42
MME P08473 1/20 0.41
FFAR1 O14842 1/20 0.41
AKR1B1 P15121 1/20 0.41
ALDH1A1 P00352 3/20 0.40
PTPN1 P18031 1/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CTSD P07339 1/20 0.39
BACE1 P56817 1/20 0.39
BACE2 Q9Y5Z0 1/20 0.39
ESR2 Q92731 1/20 0.39
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRK1 P41145 1/20 0.39
ADAM17 P78536 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1629 0.82 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2103 0.79 MYC (0.47) MYCWDR5SMN1; SMN2MMEFFAR1
SCHEMBL2686 0.77 ESR2 (0.40) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2603 0.77 MYC (0.46) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2226 0.77 MYC (0.46) MYCWDR5SMN1; SMN2MMEFFAR1
SCHEMBL1892549 0.77 MME (0.50) MYCWDR5SMN1; SMN2MMEFFAR1
SCHEMBL2200 0.77 MYC (0.45) MYCWDR5SMN1; SMN2MMEFFAR1
SCHEMBL13755333 0.76 FFAR1 (0.49) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL2432 0.76 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1
SCHEMBL8065614 0.76 MYC (0.45) MYCWDR5MMEFFAR1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965592-A HYPOTENSIVE AGENTS NOVARTIS CORPORATION (US) 1999-10-12 US disclosed
US-5399578-A Hypotensive; valsartan; high blood pressure and cardiac insufficiency CIBA-GEIGY CORP (US) 1995-03-21 US disclosed